Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Zycos begins phase II trial for treatment of cervical dysplasia

Dec. 14, 2000

Nonpeptide cathepsin D inhibitors identified at U. of California

Dec. 12, 2000

GSAO, a novel molecule with the potential to take on both cancer and HIV

Dec. 12, 2000

Phase II clinical trial of 2ME2 commences at Mayo Clinic

Dec. 12, 2000

Myriad Genetics obtains license to cancer drug in phase II

Dec. 12, 2000

Early clinical results for bryostatin 1 in hematological malignancies encouraging

Dec. 12, 2000

Cyclacel and CV Therapeutics join forces to screen anticancer compounds

Dec. 12, 2000

Roche and Aventis collaborate on Herceptin/Taxotere combination research

Dec. 12, 2000

New combretastatin prodrug displays enhanced solubility and antitumor activity

Dec. 11, 2000

Synaptic discovers peptide ligand that potentially inhibits metastasis

Dec. 11, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026